Products

Boston Scientific Corporation today announced that it has received FDA 510(k) clearance to market its SpyScope® Access and Delivery Catheter for diagnostic and therapeutic applications in the pancreatico-biliary system.

NewYork-Presbyterian Hospital and Columbia University Medical Center, together with the Cardiovascular Research Foundation, announced that its landmark study comparing the safety and efficacy of drug-eluting stents and bare-metal stents was published in the May 7 New England Journal of Medicine.

A machine developed at North Carolina State University in Raleigh may allow researchers to expedite development of new tools and techniques for heart surgery.

Boston Scientific Corporation today announced it has received approval from the U.S. Food and Drug Administration to market its TAXUS® Liberte® Atom™ Paclitaxel-Eluting Coronary Stent System.

Premier Purchasing Partners, LP, today announced new agreements for spinal implants and related products have been awarded to Aesculap Implant Systems Inc. of Center Valley, Pa.; DePuy Spine of Raynham, Mass.; and Medtronic Sofamor Danek of Memphis, Tenn.

Boston Scientific today announced that Ursula Burns and Kristina Johnson have resigned from the Company’s Board of Directors after accepting appointments in industry and government, respectively.

BSD Medical Corporation announced today that Steven M. Smith has been appointed Vice President of Marketing and Business Development.

Aircraft Medical, the UK medical devices company, today announces that it has entered the emergent Depth of Anaesthesia monitoring market with the acquisition of Morpheus Medical, the Barcelona-based developer of medical equipment.

Boston Scientific Corporation today welcomed publication of results from the ISAT clinical trial showing patients with a ruptured intracranial aneurysm treated with endovascular coil embolization are 23 percent less likely to die within five years compared to patients who undergo surgical clipping.

Ingen Technologies, Inc. announced today agreements with Emergo Global Consulting LLC to prepare and register the ISO and CE mark certifications required to market and sell Oxyview in Europe, Asia and Canada.

Tornier, Inc., a global leader in extremities orthopaedics, announced today the first human implant of a shoulder arthroplasty prosthesis based on the company’s proprietary pyrocarbon technology.

Medtronic, Inc. announced new data presented today on the safety and effectiveness of Medtronic’s CoreValve system via a novel, subclavian approach.

Direct Flow Medical, Inc. a privately held, emerging medical device Company developing a next generation, minimally invasive implant to treat patients with heart valve disease announced today the first human use of their new 18 French Percutaneous Aortic Valve (PAV) System.

Long Term Data Presented at EuroPCR 2009 from Randomized Study Attest to Durability of Results of OrbusNeich’s Genous™ Bio-engineered R stent™ Compared to Drug-Eluting Stents.

Edwards Lifesciences Corporation, the world leader in the science of heart valves, today announced at EuroPCR 2009 the results from its first post-market study of consecutively enrolled Edwards SAPIEN transcatheter aortic valve patients.

MEDRAD Interventional™/Possis® announced that it has reached key milestones in bringing the Paccocath® Technology closer to market.